Benefit by design: Determining the ‘value’ of donor human milk and medical products derived from human milk in NICU

Ben T. Hartmann

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The use of donor human milk to provide therapeutic benefit to infants should only proceed where there is positive ‘value’. This can be determined through an assessment of the benefit and the known risks. The emergence of new products derived from human milk requires new value assessments. The known hazards in human milk are modified by differences in the donor selection, processing methods and intended use and result in a unique risk assessment where any of these factors vary. The human source of the raw product requires high ethical standards in the design of these services with care taken to protect donors and recipients from harm. Any supplement to maternal milk should be provided cautiously to avoid displacement of maternal lactation.

Original languageEnglish
Article number151157
JournalSeminars in Perinatology
Volume43
Issue number7
DOIs
Publication statusPublished - 1 Nov 2019

Fingerprint Dive into the research topics of 'Benefit by design: Determining the ‘value’ of donor human milk and medical products derived from human milk in NICU'. Together they form a unique fingerprint.

Cite this